Melanoma gp100 anticorps (AA 25-467)

N° du produit ABIN7159229

Détail du produit anti-Melanoma gp100 anticorps

Antigène: Melanoma gp100 (PMEL) (Premelanosome Protein (PMEL))

Épitope: AA 25-467

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Melanoma gp100 est non-conjugé

Application: Immunohistochemistry (IHC), Western Blotting (WB), ELISA

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Melanocyte protein PMEL protein (25-467AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: WB:1:1000-1:5000, IHC:1:200-1:500,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur Melanoma gp100

Antigène: Melanoma gp100 (PMEL) (Premelanosome Protein (PMEL))

Autre désignation: PMEL (PMEL Produits)

Synonymes: anticorps D12S53E, anticorps ME20, anticorps ME20-M, anticorps ME20M, anticorps P1, anticorps P100, anticorps PMEL17, anticorps SI, anticorps SIL, anticorps SILV, anticorps gp100, anticorps D10H12S53E, anticorps D12S53Eh, anticorps Pmel17, anticorps Si, anticorps Silv, anticorps gp87, anticorps RPE1, anticorps MMP115, anticorps silverb, anticorps silver, anticorps cb397, anticorps fdv, anticorps pmel17, anticorps sb:cb397, anticorps silva, anticorps wu:fc11g11, anticorps wu:fj24g11, anticorps zgc:136622, anticorps premelanosome protein, anticorps premelanosome protein b, anticorps premelanosome protein a, anticorps PMEL, anticorps Pmel, anticorps pmelb, anticorps pmela

Sujet:

Background: Plays a central role in the biogenesis of melanosomes. Involved in the maturation of melanosomes from stage I to II. The transition from stage I melanosomes to stage II melanosomes involves an elongation of the vesicle, and the appearance within of distinct fibrillar structures. Release of the soluble form, ME20-S, could protect tumor cells from antibody mediated immunity.

Aliases: 95 kDa melanocyte specific secreted glycoprotein antibody, 95 kDa melanocyte-specific secreted glycoprotein antibody, D12S53E antibody, gp100 antibody, M-beta antibody, ME20 antibody, ME20 M/ME20 S antibody, ME20-M antibody, ME20-S antibody, ME20M antibody, ME20M/ME20S antibody, ME20S antibody, Melanocyte lineage specific antigen GP100 antibody, Melanocyte protein mel 17 antibody, Melanocyte protein Pmel 17 antibody, Melanocyte protein Pmel 17 precursor antibody, Melanocytes lineage-specific antigen GP100 antibody, Melanoma associated ME20 antigen antibody, Melanoma gp100 antibody, Melanoma-associated ME20 antigen antibody, Melanosomal matrix protein 17 antibody, Melanosomal matrix protein17 antibody, P1 antibody, p100 antibody, p26 antibody, PMEL 17 antibody, PMEL antibody, PMEL_HUMAN antibody, PMEL17 antibody, Premelanosome protein antibody, Secreted melanoma-associated ME20 antigen antibody, SI antibody, SIL antibody, SILV antibody, Silver (mouse homolog) like antibody, Silver homolog antibody, Silver locus protein homolog antibody, Silver, mouse, homolog of antibody

UniProt: P40967